KÜÇÜKTÜRKMEN, B. Et Al. 2017. Co-delivery of pemetrexed and miR-21 antisense oligonucleotide by lipid-polymer hybrid nanoparticles and effects on glioblastoma cells. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY , vol.43, no.1 , 12-21.

KÜÇÜKTÜRKMEN, B., DEVRİM GÖKBERK, B., SAKA, O. M., Yilmaz, S., Arsoy, T., & BOZKIR, A., (2017). Co-delivery of pemetrexed and miR-21 antisense oligonucleotide by lipid-polymer hybrid nanoparticles and effects on glioblastoma cells. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY , vol.43, no.1, 12-21.

KÜÇÜKTÜRKMEN, BERRİN Et Al. "Co-delivery of pemetrexed and miR-21 antisense oligonucleotide by lipid-polymer hybrid nanoparticles and effects on glioblastoma cells," DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY , vol.43, no.1, 12-21, 2017

KÜÇÜKTÜRKMEN, BERRİN Et Al. "Co-delivery of pemetrexed and miR-21 antisense oligonucleotide by lipid-polymer hybrid nanoparticles and effects on glioblastoma cells." DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY , vol.43, no.1, pp.12-21, 2017

KÜÇÜKTÜRKMEN, B. Et Al. (2017) . "Co-delivery of pemetrexed and miR-21 antisense oligonucleotide by lipid-polymer hybrid nanoparticles and effects on glioblastoma cells." DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY , vol.43, no.1, pp.12-21.

@article{article, author={BERRİN KÜÇÜKTÜRKMEN Et Al. }, title={Co-delivery of pemetrexed and miR-21 antisense oligonucleotide by lipid-polymer hybrid nanoparticles and effects on glioblastoma cells}, journal={DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY}, year=2017, pages={12-21} }